Understanding Dexmedetomidine in Neonates After Open Heart Surgery

Completed · Phase 1

Conditions studied: Tetrology of Fallot, Heart Ventricle, Hypoplastic Left Heart

In brief

The purpose of this study is to determine what happens to dexmedetomidine in the body after it has been given to a newborn after heart surgery. We want to learn how long the drug stays in the body, how the drug is metabolized by the body, and how well the medicine works at a particular dose or amount.

Key facts

Study ID
NCT00576381
Run by
Athena Zuppa
People needed
30
Starts
2006-04-01
Expected to finish
2010-12-01
Last updated by the study team
2013-04-18

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.